Indian Journal of Cancer Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2016  |  Volume : 53  |  Issue : 1  |  Page : 8--11

Tumor suppressor in lung cancer 1 gene expression in epithelial ovarian cancer

Hongmei Qu1, Feixue Xu2, Yana Bai3, Xiaoqiang Si4, Aihong Yang2 
1 College of Earth and Environmental Sciences, Lanzhou University, Medical College, Northwest University for Nationalities, Lanzhou 730000, China
2 Obstetrics and Gynecology, The First Affiliated Hospital of Lanzhou University, Lanzhou 730000, China
3 Epidemic and Health Statistics Institute, Public Health College, Lanzhou University, Lanzhou 730000, China
4 Department of Plastic Surgery, GanSu Provincial Hospital, Lanzhou 730000, China

Correspondence Address:
Feixue Xu
Obstetrics and Gynecology, The First Affiliated Hospital of Lanzhou University, Lanzhou 730000
China
Yana Bai
Obstetrics and Gynecology, The First Affiliated Hospital of Lanzhou University, Lanzhou 730000
China

Objectives: Loss of Tumor Suppressor in Lung Cancer 1(TSLC1) was observed in many different cancers, but there were only limited research on TSLC1 gene and its roles in cancer suppression in ovarian cancer. This study explores the relationship between TSLC1 gene expression and the ovarian epithelial cancer. Materials and Methods: Expression levels of TSLC1 were detected by immunohistochemical staining on formal-fixed paraffin embedded pathological specimen. A total of 259 samples were collected, including 24 benign ovarian tumor and 235 malignant ovarian cancers among them. Results: Suppressed expression of TSLC1 protein was observed in 87.8% of poorly differentiated, 85.1% of moderately differentiated, and 46% of well differentiated ovarian epithelial cancers, respectively. There were none suppressed TSLC1 expression in benign ovarian tumor. Kruskal-Wallis test showed a significant association between the expression levels of TSLC1 gene and the degree of ovarian cancer differentiation (P < 0.001). Conclusions: Decreased expression of TSLC1 is associated with the differentiation in ovarian epithelial cancer. TSLC1 might be used as a molecular marker of severity in early stage ovarian cancer, and to help differentiating benign and malignant ovarian tumors.


How to cite this article:
Qu H, Xu F, Bai Y, Si X, Yang A. Tumor suppressor in lung cancer 1 gene expression in epithelial ovarian cancer.Indian J Cancer 2016;53:8-11


How to cite this URL:
Qu H, Xu F, Bai Y, Si X, Yang A. Tumor suppressor in lung cancer 1 gene expression in epithelial ovarian cancer. Indian J Cancer [serial online] 2016 [cited 2020 Jul 13 ];53:8-11
Available from: http://www.indianjcancer.com/article.asp?issn=0019-509X;year=2016;volume=53;issue=1;spage=8;epage=11;aulast=Qu;type=0